Skip to main content
Top
Gepubliceerd in: Quality of Life Research 6/2007

01-08-2007 | Original Paper

Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer

Auteurs: Julie Lemieux, Dorcas E. Beaton, Sheilah Hogg-Johnson, Louise J. Bordeleau, Jon Hunter, Pamela J. Goodwin

Gepubliceerd in: Quality of Life Research | Uitgave 6/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

To compare the responsiveness of six questionnaires using three hypotheses of change: (i) change due to supportive-expressive group therapy (SEGT), (ii) improved mood defined as a small effect size (.2) on Profile of Mood States (POMS) Total Mood Disturbance score and (iii) progression of disease.

Method

Data from the “Breast Expressive-Supportive Therapy” study, a multicentre randomized controlled trial of change due to SEGT versus standard of care in women with metastatic breast cancer were used. Questionnaires studied were: POMS, Impact of Event Scale, Psychosocial Adjustment to Illness Scale (PAIS), EORTC QLQ-C30, Mental Adjustment to Cancer and a Pain visual analog scale (VAS). Responsiveness to change was evaluated using the standardized response mean. POMS was used as the standard.

Results

POMS was the most responsive questionnaire to change due to SEGT. Questionnaires measuring psychosocial attributes were responsive to improvement in mood. EORTC QLQ-C30, PAIS, PAIN VAS and MAC were the most responsive to disease progression. More responsive questionnaires were associated with the smallest sample size required to detect an effect.

Conclusions

Responsiveness to change is context specific. The POMS was the most responsive questionnaire to psychosocial therapy.
Literatuur
1.
go back to reference de Bruin, A. F., Diederiks, J. P., de Witte, L. P., et al. (1997). Assessing the responsiveness of a functional status measure: The sickness impact profile versus the SIP68. Journal of Clinical Epidemiology, 50, 529–540.PubMedCrossRef de Bruin, A. F., Diederiks, J. P., de Witte, L. P., et al. (1997). Assessing the responsiveness of a functional status measure: The sickness impact profile versus the SIP68. Journal of Clinical Epidemiology, 50, 529–540.PubMedCrossRef
2.
go back to reference Kirshner, B., & Guyatt, G. (1985). A methodological framework for assessing health indices. Journal of Chronic Diseases, 38, 27–36.CrossRef Kirshner, B., & Guyatt, G. (1985). A methodological framework for assessing health indices. Journal of Chronic Diseases, 38, 27–36.CrossRef
3.
go back to reference Liang, M. H., Lew, R. A., Stucki, G., et al. (2002). Measuring clinically important changes with patient-oriented questionnaires. Medical Care, 40(4 Suppl), II45–51.PubMed Liang, M. H., Lew, R. A., Stucki, G., et al. (2002). Measuring clinically important changes with patient-oriented questionnaires. Medical Care, 40(4 Suppl), II45–51.PubMed
4.
go back to reference Liang, M. H. (2000). Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Medical Care, 38(9 Suppl), II84–90.PubMed Liang, M. H. (2000). Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Medical Care, 38(9 Suppl), II84–90.PubMed
5.
go back to reference Cella, D., Bullinger, M., Scott, C., et al. (2002). Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77, 384–392.PubMedCrossRef Cella, D., Bullinger, M., Scott, C., et al. (2002). Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77, 384–392.PubMedCrossRef
6.
go back to reference Kissane, D. W., Grabsch, B., Love, A., et al. (2004). Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. The Australian and New Zealand Journal of Psychiatry, 38, 320–326.PubMedCrossRef Kissane, D. W., Grabsch, B., Love, A., et al. (2004). Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. The Australian and New Zealand Journal of Psychiatry, 38, 320–326.PubMedCrossRef
7.
go back to reference Lloyd-Williams, M., & Friedman, T. (2001). Depression in palliative care patients–a prospective study. European Journal of Cancer Care, 10, 270–274.CrossRef Lloyd-Williams, M., & Friedman, T. (2001). Depression in palliative care patients–a prospective study. European Journal of Cancer Care, 10, 270–274.CrossRef
8.
go back to reference Zabora, J., BrintzenhofeSzoc, K., Curbow, B., et al. (2001). The prevalence of psychological distress by cancer site. Psychooncology, 10, 19–28.PubMedCrossRef Zabora, J., BrintzenhofeSzoc, K., Curbow, B., et al. (2001). The prevalence of psychological distress by cancer site. Psychooncology, 10, 19–28.PubMedCrossRef
9.
go back to reference Spiegel, D., & Bloom, J. R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333–339. Spiegel, D., & Bloom, J. R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333–339.
10.
go back to reference Spiegel, D., Bloom J. R., & Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.PubMed Spiegel, D., Bloom J. R., & Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.PubMed
11.
go back to reference Cunningham, A. J., Edmonds, C. V., Jenkins, G. P., et al. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology, 7, 508–517.PubMedCrossRef Cunningham, A. J., Edmonds, C. V., Jenkins, G. P., et al. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology, 7, 508–517.PubMedCrossRef
12.
go back to reference Edelman, S., Lemon, J., Bell, D. R., et al. (1999). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology, 8, 474–481.PubMedCrossRef Edelman, S., Lemon, J., Bell, D. R., et al. (1999). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology, 8, 474–481.PubMedCrossRef
13.
go back to reference Goodwin, P. J., Leszcz, M., Ennis, M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.PubMedCrossRef Goodwin, P. J., Leszcz, M., Ennis, M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.PubMedCrossRef
14.
go back to reference Hewitt, M., Herdman, R., & Holland, J. (Eds.) (2004). Meeting psychosocial needs of women with breast cancer (1st ed., p. 278). Washigton: The National Academy Press. Hewitt, M., Herdman, R., & Holland, J. (Eds.) (2004). Meeting psychosocial needs of women with breast cancer (1st ed., p. 278). Washigton: The National Academy Press.
15.
go back to reference Bordeleau, L., Szalai, J. P., Ennis, M., et al. (2003). Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. Journal of Clinical Oncology, 21, 1944–1951.PubMedCrossRef Bordeleau, L., Szalai, J. P., Ennis, M., et al. (2003). Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. Journal of Clinical Oncology, 21, 1944–1951.PubMedCrossRef
16.
go back to reference Classen, C., Diamond, S., Soleman, A., et al. (1993). Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual. Stanford: Stanford University School of Medicine, p. 55. Classen, C., Diamond, S., Soleman, A., et al. (1993). Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual. Stanford: Stanford University School of Medicine, p. 55.
17.
go back to reference McNair D. L. M., & Droppleman, L. F. (1992). EdITS manual for the Profile of Mood States. San Diego, California 92167: EdITS/Educational and industrial testing service. McNair D. L. M., & Droppleman, L. F. (1992). EdITS manual for the Profile of Mood States. San Diego, California 92167: EdITS/Educational and industrial testing service.
18.
go back to reference Goodwin, P. J., Black, J. T., Bordeleau, L. J., et al. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. Journal of the National Cancer Institute, 95, 263–281.PubMedCrossRef Goodwin, P. J., Black, J. T., Bordeleau, L. J., et al. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. Journal of the National Cancer Institute, 95, 263–281.PubMedCrossRef
19.
go back to reference Classen, C., Butler, L. D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494–501.PubMedCrossRef Classen, C., Butler, L. D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494–501.PubMedCrossRef
20.
go back to reference Taylor, S. E., Lichtman, R. R., Wood, J. V., et al. (1985). Illness-related and treatment-related factors in psychological adjustment to breast cancer. Cancer, 55, 2506–2513.PubMedCrossRef Taylor, S. E., Lichtman, R. R., Wood, J. V., et al. (1985). Illness-related and treatment-related factors in psychological adjustment to breast cancer. Cancer, 55, 2506–2513.PubMedCrossRef
21.
go back to reference Watson, M., Greer, S., & Bliss, J. M. (1989) Mental Adjustment to Cancer (MAC) scale users’ manual. Watson, M., Greer, S., & Bliss, J. M. (1989) Mental Adjustment to Cancer (MAC) scale users’ manual.
22.
go back to reference Andritsch, E., Goldzweig, G., Samonigg, H., et al. (2004). Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: A randomized study. Support Care Cancer, 12, 10–18.PubMedCrossRef Andritsch, E., Goldzweig, G., Samonigg, H., et al. (2004). Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: A randomized study. Support Care Cancer, 12, 10–18.PubMedCrossRef
23.
go back to reference Watson, M., Haviland, J. S., Greer, S., et al. (1999). Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet, 354, 1331–1336.PubMedCrossRef Watson, M., Haviland, J. S., Greer, S., et al. (1999). Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet, 354, 1331–1336.PubMedCrossRef
24.
go back to reference Sundin, E. C., & Horowitz, M. J. (2003). Horowitz’s Impact of Event Scale evaluation of 20 years of use. Psychosomatic Medicine, 65, 870–876.CrossRef Sundin, E. C., & Horowitz, M. J. (2003). Horowitz’s Impact of Event Scale evaluation of 20 years of use. Psychosomatic Medicine, 65, 870–876.CrossRef
25.
go back to reference Kaasa, S., Malt, U., Hagen, S., et al. (1993). Psychological distress in cancer patients with advanced disease. Radiotherapy and Oncology, 27, 193–197.PubMedCrossRef Kaasa, S., Malt, U., Hagen, S., et al. (1993). Psychological distress in cancer patients with advanced disease. Radiotherapy and Oncology, 27, 193–197.PubMedCrossRef
26.
go back to reference Derogatis L. R., McNair D. M., The psychosocial adjustment to illness scale (PAIS & PAIS-SR). Administration, scoring & procedures manual-II. 1990, U.S.A. Derogatis L. R., McNair D. M., The psychosocial adjustment to illness scale (PAIS & PAIS-SR). Administration, scoring & procedures manual-II. 1990, U.S.A.
27.
go back to reference Friedman, L. C., Baer, P. E., Nelson, D. V., et al., (1988). Women with breast cancer: Perception of family functioning and adjustment to illness. Psychosomatic Medicine, 50, 529–540.PubMed Friedman, L. C., Baer, P. E., Nelson, D. V., et al., (1988). Women with breast cancer: Perception of family functioning and adjustment to illness. Psychosomatic Medicine, 50, 529–540.PubMed
28.
go back to reference Merluzzi, T. V., &. Martinez Sanchez. M. A., (1997). Factor structure of the psychosocial adjustment to illness scale (self-report) for persons with cancer. Psychological Assessment, 9, 269–276. Merluzzi, T. V., &. Martinez Sanchez. M. A., (1997). Factor structure of the psychosocial adjustment to illness scale (self-report) for persons with cancer. Psychological Assessment, 9, 269–276.
29.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., et al., (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., et al., (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
30.
go back to reference Bottomley, A., Biganzoli, L., Cufer, T., et al., (2004). Randomized, controlled trial investigating short-term health-related quality of life with Doxorubicin and Paclitaxel versus Doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, investigational drug branch for breast cancer and the new drug development group study. Journal of Clinical Oncology, 22, 2576–2586.PubMedCrossRef Bottomley, A., Biganzoli, L., Cufer, T., et al., (2004). Randomized, controlled trial investigating short-term health-related quality of life with Doxorubicin and Paclitaxel versus Doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, investigational drug branch for breast cancer and the new drug development group study. Journal of Clinical Oncology, 22, 2576–2586.PubMedCrossRef
31.
go back to reference McLachlan, S. A., Devins G. M., & Goodwin, P. J. (1998). Validation of the European organization for research and treatment of cancer quality of life questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. European Journal of Cancer, 34, 510–517.PubMedCrossRef McLachlan, S. A., Devins G. M., & Goodwin, P. J. (1998). Validation of the European organization for research and treatment of cancer quality of life questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. European Journal of Cancer, 34, 510–517.PubMedCrossRef
32.
go back to reference Hjermstad, M. J., Fossa, S. D., Bjordal, K., et al., (1995). Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. Journal of Clinical Oncology, 13, 1249–1254.PubMed Hjermstad, M. J., Fossa, S. D., Bjordal, K., et al., (1995). Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. Journal of Clinical Oncology, 13, 1249–1254.PubMed
33.
go back to reference Osoba, D., Rodrigues, G., Myles, J., et al., (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144.PubMed Osoba, D., Rodrigues, G., Myles, J., et al., (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144.PubMed
34.
go back to reference Clark, P., Lavielle P., & Martinez, H., (2003). Learning from pain scales: Patient perspective. The Journal of Rheumatology, 30, 1584–1588.PubMed Clark, P., Lavielle P., & Martinez, H., (2003). Learning from pain scales: Patient perspective. The Journal of Rheumatology, 30, 1584–1588.PubMed
35.
go back to reference Cohen J., (1988). Statistical power analysis for the behavioral sciences. (2nd ed, p. 567). Hillsdale, New Jersey: Lawrence Erlbaum Associates. Cohen J., (1988). Statistical power analysis for the behavioral sciences. (2nd ed, p. 567). Hillsdale, New Jersey: Lawrence Erlbaum Associates.
36.
go back to reference Samsa, G., Edelman, D., Rothman, M. L., et al., (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141–155.PubMedCrossRef Samsa, G., Edelman, D., Rothman, M. L., et al., (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141–155.PubMedCrossRef
37.
go back to reference Geels, P., Eisenhauer, E., Bezjak, A., et al., (2000). Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. Journal of Clinical Oncology, 18, 2395–2405.PubMed Geels, P., Eisenhauer, E., Bezjak, A., et al., (2000). Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. Journal of Clinical Oncology, 18, 2395–2405.PubMed
38.
go back to reference Zou, G. Y., (2005). Quantifying responsiveness of quality of life measures without an external criterion. Quality of Life Research, 14, 1545–1552.PubMedCrossRef Zou, G. Y., (2005). Quantifying responsiveness of quality of life measures without an external criterion. Quality of Life Research, 14, 1545–1552.PubMedCrossRef
39.
go back to reference Lemieux, J., Beaton, D. E., S. Hogg-Johnson, et al., (2006). Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology (in press). Lemieux, J., Beaton, D. E., S. Hogg-Johnson, et al., (2006). Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology (in press).
40.
go back to reference Schwartz, C. E., Bode, R., Repucci, N., et al., (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1503–1508.PubMedCrossRef Schwartz, C. E., Bode, R., Repucci, N., et al., (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1503–1508.PubMedCrossRef
41.
go back to reference Holzner, B., Kemmler, G., Sperner-Unterweger, B., et al., (2001). Quality of life measurement in oncology–a matter of the assessment instrument? European Journal of Cancer, 37, 2349–2356.PubMedCrossRef Holzner, B., Kemmler, G., Sperner-Unterweger, B., et al., (2001). Quality of life measurement in oncology–a matter of the assessment instrument? European Journal of Cancer, 37, 2349–2356.PubMedCrossRef
42.
go back to reference Wilson, R. W., Hutson L. M., & Vanstry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Physical Therapy, 85, 851–860.PubMed Wilson, R. W., Hutson L. M., & Vanstry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Physical Therapy, 85, 851–860.PubMed
Metagegevens
Titel
Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer
Auteurs
Julie Lemieux
Dorcas E. Beaton
Sheilah Hogg-Johnson
Louise J. Bordeleau
Jon Hunter
Pamela J. Goodwin
Publicatiedatum
01-08-2007
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 6/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9208-2

Andere artikelen Uitgave 6/2007

Quality of Life Research 6/2007 Naar de uitgave